We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s Center for Biologics Evaluation and Research (CBER) Director Peter Marks said Wednesday that he hopes the center can help expedite vaccine development to lead to a COVID-19 vaccine in nine months. Read More
Pfizer and BioNTech have started a U.S. trial of COVID-19 vaccine candidates at the NYU Grossman School of Medicine and the University of Maryland School of Medicine. Read More
More than a dozen countries — with the notable exception of the United States — have pledged to contribute approximately $8 billion to develop potential COVID-19 vaccines and treatments. Read More
Blood pressure medications do not increase the risk of contracting COVID-19 or of serious illness or death in COVID-19 patients as previously thought, three large observational studies showed. Read More